0.25
Plus Therapeutics Inc Azioni (PSTV) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
0.50%
1.397
|
1.39 | 1.059 | 1.412 | 1.456 |
|
|
100.79%
5.879
|
2.928 | 4.595 | 5.312 | 5.255 |
| Benefits Costs and Expenses |
-
|
- | - | -13.49 | 4.33 |
| Costs And Expenses |
100.79%
5.879
|
2.928 | 4.595 | 5.312 | 5.255 |
| Operating Income/Loss |
191.42%
-4.482
|
-1.538 | -3.536 | -3.90 | -3.799 |
| Nonoperating Income/Loss |
99.12%
0.059
|
6.689 | -13.87 | -0.003 | 0.925 |
| Income/Loss From Continuing Operations Before Tax |
72.88%
1.397
|
5.151 | -17.40 | 14.90 | -2.874 |
| Income/Loss From Continuing Operations After Tax |
185.87%
-4.423
|
5.151 | -17.40 | -3.903 | -2.874 |
|
|
185.87%
-4.423
|
5.151 | -17.40 | -3.903 | -2.874 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
122.01%
107.43
|
48.39 | 14.57 | 0.4081 | 7.8558 |
| Diluted Average Shares |
48.64%
107.43
|
209.15 | 14.57 | -0.7516 | 7.8558 |
| Basic Earnings Per Share |
300.00%
-0.04
|
0.02 | -1.19 | -0.49 | -0.37 |
| Diluted Earnings Per Share |
300.00%
-0.04
|
-0.01 | -1.19 | -0.67 | -0.37 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):